Cellular senescence: when bad things happen to good cells (original) (raw)

• Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636 (1965). A classic paper that describes the limited replicative lifespan of normal human cells.
  CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  CAS PubMed Google Scholar
• Bishop, J. M. Cancer: the rise of the genetic paradigm. Genes Dev. 9, 1309–1315 (1995). References 2 and 3 describe the characteristics of cancer cells and the importance of mutations in cancer development.
  CAS PubMed Google Scholar
• Busuttil, R. A., Rubio, M., Dolle, M. E., Campisi, J. & Vijg, J. Mutant frequencies and spectra depend on growth state and passage number in cells cultured from transgenic _lacZ_-plasmid reporter mice. DNA Repair 5, 52–60 (2006).
  CAS PubMed Google Scholar
• Sager, R. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93, 59–62 (1991).
  CAS PubMed PubMed Central Google Scholar
• Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, 27–31 (2001).
  Google Scholar
• Braig, M. & Schmitt, C. A. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 66, 2881–2884 (2006).
  CAS PubMed Google Scholar
• Campisi, J. Cancer and ageing: rival demons? Nature Rev. Cancer 3, 339–349 (2003).
  CAS Google Scholar
• Kirkwood, T. B. & Austad, S. N. Why do we age? Nature 408, 233–238 (2000).
  CAS PubMed Google Scholar
• Dimri, G. P. What has senescence got to do with cancer? Cancer Cell 7, 505–512 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wright, W. E. & Shay, J. W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11, 98–103 (2001).
  CAS PubMed Google Scholar
• Campisi, J. Senescent cells, tumor suppression and organismal aging: good citizens, bad neighbors. Cell 120, 513–522 (2005).
  CAS PubMed Google Scholar
• Hornsby, P. J. Cellular senescence and tissue aging in vivo. J. Gerontol. 57, 251–256 (2002). References 5–13 describe the historic and current evidence that cellular senescence suppresses the development of cancer. In addition, references 8 and 9 explain the concept of antagonistic pleiotropy.
  Google Scholar
• Kim, W. Y. & Sharpless, N. E. The regulation of INK4/ARF in cancer and aging. Cell 127, 265–275 (2006).
  CAS PubMed Google Scholar
• DiLeonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
  CAS Google Scholar
• Herbig, U., Jobling, W. A., Chen, B. P., Chen, D. J. & Sedivy, J. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14, 501–513 (2004).
  CAS PubMed Google Scholar
• Ogryzko, V. V., Hirai, T. H., Russanova, V. R., Barbie, D. A. & Howard, B. H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16, 5210–5218 (1996).
  CAS PubMed PubMed Central Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
  Article CAS PubMed Google Scholar
• Wada, T. et al. MKK7 couples stress signaling to G2/M cell-cycle progression and cellular senescence. Nature Cell Biol. 6, 215–226 (2004).
  CAS PubMed Google Scholar
• Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638–642 (2006).
  CAS PubMed Google Scholar
• Olsen, C. L., Gardie, B., Yaswen, P. & Stampfer, M. R. Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene 21, 6328–6339 (2002).
  CAS PubMed Google Scholar
• Zhu, J., Woods, D., McMahon, M. & Bishop, J. M. Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 12, 2997–3007 (1998).
  CAS PubMed PubMed Central Google Scholar
• Shay, J. W. & Roninson, I. B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23, 2919–2933 (2004). References 15–23 show that many potentially oncogenic stimuli can induce a senescence response.
  CAS PubMed Google Scholar
• Itahana, K., Campisi, J. & Dimri, G. P. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5, 1–10 (2004).
  CAS PubMed Google Scholar
• Ellis, R. E., Yuan, J. Y. & Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663–698 (1991).
  CAS PubMed Google Scholar
• Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19–30 (2002).
  CAS PubMed Google Scholar
• Hampel, B., Malisan, F., Niederegger, H., Testi, R. & Jansen-Durr, P. Differential regulation of apoptotic cell death in senescent human cells. Exp. Gerontol. 39, 1713–1721 (2004).
  CAS PubMed Google Scholar
• Chen, Q. M., Liu, J. & Merrett, J. B. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem. J. 347, 543–551 (2000).
  CAS PubMed PubMed Central Google Scholar
• Tepper, C. G., Seldin, M. F. & Mudryj, M. Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. Exp. Cell Res. 260, 9–19 (2000).
  CAS PubMed Google Scholar
• Rebbaa, A., Zheng, X., Chou, P. M. & Mirkin, B. L. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22, 2805–2811 (2003).
  CAS PubMed Google Scholar
• Seluanov, A. et al. Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol. Cell. Biol. 21, 1552–1564 (2001).
  CAS PubMed PubMed Central Google Scholar
• Crescenzi, E., Palumbo, G. & Brady, H. J. Bcl-2 activates a programme of premature senescence in human carcinoma cells. Biochem. J. 375, 263–274 (2003).
  CAS PubMed PubMed Central Google Scholar
• Marcotte, R., Lacelle, C. & Wang, E. Senescent fibroblasts resist apoptosis by downregulating caspase-3. Mech. Ageing Dev. 125, 777–783 (2004).
  CAS PubMed Google Scholar
• Murata, Y. et al. Death-associated protein 3 regulates cellular senescence through oxidative stress response. FEBS Lett. 580, 6093–6099 (2006).
  CAS PubMed Google Scholar
• Jackson, J. G. & Pereira-Smith, O. M. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Res. 66, 8356–8360 (2006).
  CAS PubMed Google Scholar
• Chang, B. D. et al. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl Acad. Sci. USA 99, 389–394 (2002).
  CAS PubMed Google Scholar
• Mason, D. X., Jackson, T. J. & Lin, A. W. Molecular signature of oncogenic ras-induced senescence. Oncogene 23, 9238–9246 (2004).
  CAS PubMed Google Scholar
• Shelton, D. N., Chang, E., Whittier, P. S., Choi, D. & Funk, W. D. Microarray analysis of replicative senescence. Curr. Biol. 9, 939–945 (1999).
  CAS PubMed Google Scholar
• Trougakos, I. P., Saridaki, A., Panayotou, G. & Gonos, E. S. Identification of differentially expressed proteins in senescent human embryonic fibroblasts. Mech. Ageing Dev. 127, 88–92 (2006).
  CAS PubMed Google Scholar
• Yoon, I. K. et al. Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp. Gerontol. 39, 1369–1378 (2004).
  CAS PubMed Google Scholar
• Zhang, H., Pan, K. H. & Cohen, S. N. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc. Natl Acad. Sci. USA 100, 3251–3256 (2003). References 36–41 describe the many changes in gene expression that are linked to the senescence response.
  CAS PubMed PubMed Central Google Scholar
• Sherr, C. J. & McCormick, F. The RB and p53 pathways in cancer. Cancer Cell 2, 103–112 (2002).
  CAS PubMed Google Scholar
• Espinosa, J. M., Verdun, R. E. & Emerson, B. M. p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol. Cell 12, 1015–1027 (2003).
  CAS PubMed Google Scholar
• Gil, J. & Peters, G. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all. Nature Rev. Mol. Cell Biol. 7, 667–677 (2006).
  CAS Google Scholar
• Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703–716 (2003). The first description of senescence-associated heterochromatin foci.
  CAS PubMed Google Scholar
• Pang, J. H. & Chen, K. Y. Global change of gene expression at late G1/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J. Cell Physiol. 160, 531–538 (1994).
  CAS PubMed Google Scholar
• Seshadri, T. & Campisi, J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 247, 205–209 (1990).
  CAS PubMed Google Scholar
• Stein, G. H., Drullinger, L. F., Robetorye, R. S., Pereira-Smith, O. M. & Smith, J. R. Senescent cells fail to express CDC2, CYCA, and CYCB in response to mitogen stimulation. Proc. Natl Acad. Sci USA 88, 11012–11016 (1991).
  CAS PubMed PubMed Central Google Scholar
• Dimri, G. P. et al. A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995). First description of a senescence-associated marker that allowed the identification of senescent cells in vivo.
  CAS PubMed PubMed Central Google Scholar
• Lee, B. Y. et al. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 5, 187–195 (2006).
  CAS PubMed Google Scholar
• Krishnamurthy, J. et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299–1307 (2004).
  CAS PubMed PubMed Central Google Scholar
• Beausejour, C. M. et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22, 4212–4222 (2003).
  CAS PubMed PubMed Central Google Scholar
• Itahana, K. et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23, 389–401 (2003).
  CAS PubMed PubMed Central Google Scholar
• Collado, M. & Serrano, M. The power and the promise of oncogene-induced senescence markers. Nature Rev. Cancer 6, 472–476 (2006).
  CAS Google Scholar
• d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003).
  CAS PubMed Google Scholar
• Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549–1556 (2003). References 55 and 56, along with reference 16, provide the first direct evidence that dysfunctional telomeres trigger a DNA-damage response.
  CAS PubMed Google Scholar
• Bartholdi, M. F. Nuclear distribution of centromeres during the cell cycle of human diploid fibroblasts. J. Cell Sci. 99, 255–263 (1991).
  PubMed Google Scholar
• Cerda, M. C., Berrios, S., Fernandez-Donoso, R., Garagna, S. & Redi, C. Organisation of complex nuclear domains in somatic mouse cells. Biol. Cell 91, 55–65 (1999).
  CAS PubMed Google Scholar
• d'Adda di Fagagna, F., Teo, S. H. & Jackson, S. P. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 18, 1781–1799 (2004).
  PubMed Google Scholar
• Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 503–514 (1999).
  CAS PubMed Google Scholar
• Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during aging of human fibroblasts. Nature 345, 458–460 (1990). First evidence linking telomere shortening to replicative senescence.
  CAS PubMed Google Scholar
• Hemann, M. T., Strong, M.A., Hao, L. Y. & Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67–77 (2001).
  CAS PubMed Google Scholar
• Martens, U. M., Chavez, E. A., Poon, S. S., Schmoor, C. & Lansdorp, P. M. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp. Cell Res. 256, 291–299 (2000).
  CAS PubMed Google Scholar
• Gire, V., Roux, P., Wynford-Thomas, D., Brondello, J. M. & Dulic, V. DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J. 23, 2554–2563 (2004).
  CAS PubMed PubMed Central Google Scholar
• Collins, K. & Mitchell, J. R. Telomerase in the human organism. Oncogene 21, 564–579 (2002).
  CAS PubMed Google Scholar
• Effros, R. B., Dagarag, M. & Valenzuela, H. F. In vitro senescence of immune cells. Exp. Gerontol. 38, 1243–1249 (2003).
  CAS PubMed Google Scholar
• Masutomi, K. et al. Telomerase maintains telomere structure in normal human cells. Cell 114, 241–253 (2003).
  CAS PubMed Google Scholar
• Bodnar, A. G. et al. Extension of life span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
  CAS PubMed Google Scholar
• Chen, Q. M., Prowse, K. R., Tu, V. C., Purdom, S. & Linskens, M. H. Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts. Exp. Cell Res. 265, 294–303 (2001).
  CAS PubMed Google Scholar
• Parrinello, S. et al. Oxygen sensitivity severely limits the replicative life span of murine cells. Nature Cell Biol. 5, 741–747 (2003).
  CAS PubMed Google Scholar
• Jacobs, J. J. & de Lange, T. Significant role for p16(INK4a) in p53-independent telomere-directed senescence. Curr. Biol. 14, 2302–2308 (2004).
  CAS PubMed Google Scholar
• Stein, G. H., Drullinger, L. F., Soulard, A. & Dulic, V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19, 2109–2117 (1999).
  CAS PubMed PubMed Central Google Scholar
• Roninson, I. B. Tumor cell senescence in cancer treatment. Cancer Res. 63, 2705–2715 (2003).
  CAS PubMed Google Scholar
• Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S. Y. & Wu, D. Y. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res. 65, 2795–2803 (2005).
  CAS PubMed Google Scholar
• Schmitt, C. A. et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335–346 (2002).
  CAS PubMed Google Scholar
• te Poele, R. H., Okorokov, A. L., Jardine, L., Cummings, J. & Joel, S. P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876–1883 (2002). References 73–76 describe evidence that tumour cells can undergo senescence in response to DNA-damaging chemotherapy.
  CAS PubMed Google Scholar
• Munro, J., Barr, N. I., Ireland, H., Morrison, V. & Parkinson, E. K. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp. Cell Res. 295, 525–538 (2004).
  CAS PubMed Google Scholar
• Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499–506 (2003).
  CAS PubMed Google Scholar
• Bandyopadhyay, D. et al. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res. 62, 6231–6239 (2002).
  CAS PubMed Google Scholar
• Minucci, S. & Pelicci, P. G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nature Rev. Cancer 6, 38–51 (2006).
  CAS Google Scholar
• Dimri, G. P., Itahana, K., Acosta, M. & Campisi, J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14/ARF tumor suppressor. Mol. Cell. Biol. 20, 273–285 (2000).
  CAS PubMed PubMed Central Google Scholar
• Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008–3019 (1998).
  CAS PubMed PubMed Central Google Scholar
• Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human nevi. Nature 436, 720–724 (2005).
  CAS PubMed Google Scholar
• Woo, R. A. & Poon, R. Y. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev. 18 (2004).
• Mathon, N. F., Malcolm, D. S., Harrisingh, M. C., Cheng, L. & Lloyd, A. C. Lack of replicative senescence in normal rodent glia. Science 291, 872–875 (2001).
  CAS PubMed Google Scholar
• Tang, D. G., Tokumoto, Y. M., Apperly, J. A., Lloyd, A. C. & Raff, M. C. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291, 868–871 (2001).
  CAS PubMed Google Scholar
• Ohtani, N. et al. Opposing effects of Ets and Id proteins on p16/INK4a expression during cellular senescence. Nature 409, 1067–1070 (2001).
  CAS PubMed Google Scholar
• Zhang, R. et al. Formation of macroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8, 19–31 (2005).
  CAS PubMed Google Scholar
• Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633–637 (2006).
  CAS PubMed Google Scholar
• Benanti, J. A. & Galloway, D. A. Normal human fibroblasts are resistant to RAS-induced senescence. Mol. Cell. Biol. 24, 2842–2852 (2004).
  CAS PubMed PubMed Central Google Scholar
• Skinner, J. et al. Opposing effects of mutant ras oncoprotein on human fibroblast and epithelial cell proliferation: implications for models of human tumorigenesis. Oncogene 23, 5994–5999 (2004).
  CAS PubMed Google Scholar
• Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005).
  CAS PubMed Google Scholar
• Chen, Z. et al. Critical role of p53-dependent cellular senescence in suppression of PTEN-deficient tumorigenesis. Nature 436, 725–730 (2005).
  CAS PubMed PubMed Central Google Scholar
• Collado, M. et al. Identification of senescent cells in premalignant tumours. Nature 436, 642 (2005).
  CAS PubMed Google Scholar
• Lazzerini Denchi, E., Attwooll, C., Pasini, D. & Helin, K. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol. Cell. Biol. 25, 2660–2672 (2005). Together with references 83 and 89, references 92–95 provide evidence that cellular senescence suppresses tumorigenesis in vivo.
  PubMed Google Scholar
• Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A. & Ferbeyre, G. DNA damage signaling and p53-dependent senescence after prolonged β-interferon stimulation. Mol. Biol. Cell 17, 1583–1592 (2006).
  CAS PubMed PubMed Central Google Scholar
• Vijayachandra, K., Lee, J. & Glick, A. B. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res. 63, 3447–3452 (2003).
  CAS PubMed Google Scholar
• Zhang, H. & Cohen, S. N. Smurf2 up-regulation activates telomere-dependent senescence. Genes Dev. 18, 3028–3040 (2004).
  CAS PubMed PubMed Central Google Scholar
• Ramirez, R. D. et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398–403 (2001).
  CAS PubMed PubMed Central Google Scholar
• Brenner, A. J., Stampfer, M. R. & Aldaz, C. M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17, 199–205 (1998).
  CAS PubMed Google Scholar
• Huschtscha, L. I. et al. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58, 3508–3512 (1998).
  CAS PubMed Google Scholar
• Forsyth, N. R., Evans, A. P., Shay, J. W. & Wright, W. E. Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell 2, 235–243 (2003).
  CAS PubMed Google Scholar
• Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene BMI-1 regulates cell proliferation and senescence through the INK4a locus. Nature 397, 164–168 (1999).
  CAS PubMed Google Scholar
• Zindy, F., Quelle, D. E., Roussel, M. F. & Sherr, C. J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203–211 (1997). First report that p16 expression increases during ageing.
  CAS PubMed Google Scholar
• Janzen, V. et al. Stem cell aging modified by the cyclin-dependent kinase inhibitor, p16INK4a. Nature 443, 421–426 (2006).
  CAS PubMed Google Scholar
• Krishnamurthy, J. et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453–457 (2006).
  CAS PubMed Google Scholar
• Molofsky, A. V. et al. Declines in forebrain progenitor function and neurogenesis during aging are partially caused by increasing Ink4a expression. Nature 443, 448–452 (2006). References 105–107 describe evidence that p16 limits stem-cell or progenitor-cell proliferation, which drives ageing phenotypes.
  CAS PubMed PubMed Central Google Scholar
• Holst, C. R. et al. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596–1601 (2003).
  CAS PubMed Google Scholar
• Brown, J. P., Wei, W. & Sedivy, J. M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831–834 (1997).
  CAS PubMed Google Scholar
• Won, J. et al. Small molecule-based reversible reprogramming of cellular lifespan. Nature Chem. Biol. 2, 369–374 (2006).
  CAS Google Scholar
• Shay, J. W. & Wright, W. E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26, 867–874 (2005).
  CAS PubMed Google Scholar
• Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864–870 (2005).
  CAS PubMed Google Scholar
• Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907–913 (2005).
  CAS PubMed Google Scholar
• Smogorzewska, A. & de Lange, T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338–4348 (2002).
  CAS PubMed PubMed Central Google Scholar
• Hara, E. et al. Id related genes encoding helix loop helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 269, 2139–2145 (1994).
  CAS PubMed Google Scholar
• Bracken, A. P. et al. The Polycomb group proteins bind throughout the INK4A–ARF locus and are disassociated in senescent cells. Genes Dev. 21, 525–530 (2007).
  CAS PubMed PubMed Central Google Scholar
• Gil, J., Bernard, D., Martinez, D. & Beach, D. Polycomb CBX7 has a unifying role in cellular lifespan. Nature Cell Biol. 6, 62–67 (2004).
  Google Scholar
• Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  CAS PubMed Google Scholar
• Bates, S. et al. p14ARF links the tumor suppressors RB and p53. Nature 395, 125–125 (1998).
  Google Scholar
• Zhang, J., Pickering, C. R., Holst, C. R., Gauthier, M. L. & Tlsty, T. D. p16INK4a modulates p53 in primary human mammary epithelial cells. Cancer Res. 66, 10325–10331 (2006).
  CAS PubMed Google Scholar
• Funayama, R., Saito, M., Tanobe, H. & Ishikawa, F. Loss of linker histone H1 in cellular senescence. J. Cell Biol. 175, 869–880 (2006).
  CAS PubMed PubMed Central Google Scholar
• Zhang, R., Chen, W. & Adams, P. D. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol. Cell. Biol. 27, 2343–2358 (2007).
  CAS PubMed PubMed Central Google Scholar
• Macaluso, M., Montanari, M. & Giordano, A. Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes. Oncogene 25, 5263–5267 (2006).
  CAS PubMed Google Scholar
• Jeyapalan, J. C., Ferreira, M., Sedivy, J. M. & Herbig, U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128, 36–44 (2007).
  CAS PubMed Google Scholar
• Chang, E. & Harley, C. B. Telomere length and replicative aging in human vascular tissues. Proc. Natl Acad. Sci. USA 92, 11190–11194 (1995).
  CAS PubMed PubMed Central Google Scholar
• Price, J. S. et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1, 57–65 (2002).
  CAS PubMed Google Scholar
• Vasile, E., Tomita, Y., Brown, L. F., Kocher, O. & Dvorak, H. F. Differential expression of thymosin β-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: Evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15, 458–466 (2001).
  CAS PubMed Google Scholar
• Castro, P., Giri, D., Lamb, D. & Ittmann, M. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55, 30–38 (2003).
  CAS PubMed Google Scholar
• Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).
  CAS PubMed Google Scholar
• Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–650 (2007).
  CAS PubMed PubMed Central Google Scholar
• Cosme-Blanco, W. et al. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep. 8, 497–503 (2007).
  CAS PubMed PubMed Central Google Scholar
• Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B. & Evan, G. I. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443, 214–217 (2006).
  CAS PubMed Google Scholar
• Feldser, D. M. & Greider, C. W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11, 461–469 (2007).
  CAS PubMed PubMed Central Google Scholar
• Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356, 215–221 (1992).
  CAS PubMed Google Scholar
• Iwakuma, T., Lozano, G. & Flores, E. R. Li-Fraumeni syndrome: a p53 family affair. Cell Cycle 4, 865–867 (2005).
  CAS PubMed Google Scholar
• Lee, S. B. et al. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res. 61, 8062–8067 (2001).
  CAS PubMed Google Scholar
• Shay, J. W., Tomlinson, G., Piatyszek, M. A. & Gollahon, L. S. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol. Cell Biol. 15, 425–432 (1995).
  CAS PubMed PubMed Central Google Scholar
• Morales, C. P. et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet. 21, 115–118 (1999).
  CAS PubMed Google Scholar
• Shay, J. W., Van Der Haegen, B. A., Ying, Y. & Wright, W. E. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp. Cell Res. 209, 45–52 (1993).
  CAS PubMed Google Scholar
• Hahn, W. C. et al. Creation of human tumor cells with defined genetic elements. Nature 400, 464–468 (1999).
  CAS PubMed Google Scholar
• Tyner, S. D. et al. p53 mutant mice that display early aging-associated phenotypes. Nature 415, 45–53 (2002).
  CAS PubMed Google Scholar
• Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306–319 (2004). References 141 and 142 show that constitutive p53 activity can suppress the development of cancer at the cost of accelerating ageing phenotypes.
  CAS PubMed PubMed Central Google Scholar
• Funk, W. D. et al. Telomerase expression restores dermal integrity to in vitro aged fibroblasts in a reconstituted skin model. Exp. Cell Res. 258, 270–278 (2000).
  CAS PubMed Google Scholar
• Parrinello, S., Coppe, J. P., Krtolica, A. & Campisi, J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118, 485–496 (2005).
  CAS PubMed Google Scholar
• Bavik, C. et al. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 66, 794–802 (2006).
  CAS PubMed Google Scholar
• Coppe, J. P., Kauser, K., Campisi, J. & Beausejour, C. M. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281, 29568–29574 (2006).
  CAS PubMed Google Scholar
• Dilley, T. K., Bowden, G. T. & Chen, Q. M. Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. Exp. Cell Res. 290, 38–48 (2003).
  CAS PubMed Google Scholar
• Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072–12077 (2001).
  CAS PubMed PubMed Central Google Scholar
• Martens, J. W. et al. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Thromb. Haemost. 89, 393–404 (2003).
  CAS PubMed Google Scholar
• Garcia-Cao, I. et al. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21, 6225–6235 (2002).
  CAS PubMed PubMed Central Google Scholar
• Matheu, A. et al. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 18, 2736–2746 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mendrysa, S. M. et al. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev. 20, 16–21 (2006). References 150–152 show that resistance to cancer need not accelerate ageing.
  CAS PubMed PubMed Central Google Scholar
• Shay, J. W., Wright, W. E. & Werbin, H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta Rev. Cancer 1071, 1–7 (1991).
  Google Scholar
• Romanov, S. R. et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409, 633–637 (2001).
  CAS PubMed Google Scholar
• Emsley, J. G., Mitchell, B. D., Kempermann, G. & Macklis, J. D. Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog. Neurobiol. 75, 321–341 (2005).
  CAS PubMed Google Scholar
• Shi, X. & Garry, D. J. Muscle stem cells in development, regeneration, and disease. Genes Dev. 20, 1692–1708 (2006).
  CAS PubMed Google Scholar
• Srivastava, D. & Ivey, K. N. Potential of stem-cell-based therapies for heart disease. Nature 441, 1097–1099 (2006).
  CAS PubMed Google Scholar